Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Renaissance of ares publica clinical research: global access to trial registers

  • 29 Accesses

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Rennie D. Trial registration: a great idea switches from ignored to irresistible.JAMA 2004; 292: 1359–62.

  2. 2.

    De Angelis CD, Drazen JM, Frizelle FA, et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors.Lancet 2005; 365: 1827–9.

  3. 3.

    World Health Organization International Clinical Trials Registry Platform. Trial Registration Data Set. Geneva: World Health Organization, 2006. Available:http://www.who.int/ictrp/data_set/en [Accessed 1 October 2006].

  4. 4.

    World Health Organization: International Clinical Trials Registry Platform. Geneva, Switzerland: World Health Organization, 2006. Available:http://www.who.int/ictrp/en [Accessed 1 October 2006].

  5. 5.

    ClinicalTrials.gov, 2006. Available: http://www. clinicaltrials.gov [Accessed 1 October 2006].

  6. 6.

    Current Controlled Trials Ltd. ISRCTN Register, 2006. Available: http://www.isrctn.org [Accessed 1 October 2006].

  7. 7.

    The Ottawa Group. Ottawa Statement in trial registration, 2006. Available: http://ottawagroup.ohri.ca [Accessed 1 October 2006.]

  8. 8.

    Krleza-Jeric K, Chan AW, Dickersin K, et al. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1).BMJ 2005; 330: 956–8.

  9. 9.

    Decreto Legislativo no. 211 of 24 June 2003. Available: http://oss-sper-clin.sanita.it/normativa/decreto_24062003_ inglese.pdf [Accessed 1 October 2006].

  10. 10.

    Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.JAMA 2004; 291: 2457–65.

Download references

Author information

Correspondence to Lorenzo Moja.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Moja, L., Moschetti, I., Liberati, A. et al. Renaissance of ares publica clinical research: global access to trial registers. Int Emergency Med 1, 310–311 (2006). https://doi.org/10.1007/BF02934767

Download citation

Keywords

  • Medical Journal Editor
  • International Clinical Trial Registry Platform
  • Control Trial International Standard Randomise
  • Standard Randomise Control Trial Number
  • Selective Reporting Bias